investorscraft@gmail.com

Stock Analysis & ValuationQuoin Pharmaceuticals, Ltd. (QNRX)

Previous Close
$6.21
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)n/an/a
Intrinsic value (DCF)n/a
Graham-Dodd Methodn/a
Graham Formulan/a

Company Information

42127 Pleasant Forest Court
Ashburn, VA 20148-7349
United States
Phone: 703 980 4182
Industry: Biotechnology
Sector: Healthcare
CEO: Michael Myers
Full Time Employees: 3

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.

HomeMenuAccount